India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Mot 128.55 0.77
Tata Pow 64.35 0.08
Ong Corp 130.65 1.44
State Ba 284.65 2.42
Kotak Ba 1470.60 0.87
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
Market Lot: 1Face Value: 2ISIN Demat: INE901L01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
12-Feb-2019       Alembic Pharma announces completion of USFDA inspection at Aleor Dermaceuticals IRIS
05-Dec-2018       Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets IRIS
28-Nov-2018       Alembic Pharma gets USFDA approval for Temazepam capsules IRIS
22-Oct-2018       Alembic Pharma' JV completes USFDA inspection of Karakhadi unit IRIS
06-Aug-2018       Alembic Pharma gets tentative nod for Bimatoprost Ophthalmic solution IRIS
12-Jul-2018       Alembic Pharma receives USFDA tentative approval for lloperidone Tablets IRIS
12-Jul-2018       Alembic Pharma gets USFDA tentative approval for Ticagrelor Tablets IRIS
15-Jun-2018       Alembic Pharma receives EIR for formulation facility at Panelav IRIS
14-Jun-2018       Alembic Pharma receives nod for Doxycycline Hyclate capsules IRIS
11-Jun-2018       Alembic Pharma gets nod for Bupropion HCl tablets IRIS
17-May-2018       Alembic Pharma quarterly earnings rise 0.81%  IRIS
24-Apr-2018       Alembic Pharma announces USFDA inspection of API facility IRIS
09-Apr-2018       Alembic Pharma gets USFDA nod for Acyclovir ointment IRIS
21-Mar-2018       Alembic Pharm intimates of USFDA inspection of facility at Panelav IRIS
26-Dec-2017       Alembic Pharma intimates of grant of orphan drug designation IRIS
12-Dec-2017       Alembic Pharma gets USFDA's nod for Darifenacin tablets IRIS
11-Dec-2017       Alembic Pharma's arm gets fast track designation for RP6530 IRIS
01-Nov-2017       Alembic Pharma acquires Orit Laboratories LLC IRIS
24-Aug-2017       Alembic Pharma sells formulations manufacturing facility at Baddi to SEPL IRIS
31-Jul-2017       Alembic Pharma gets USFDA nod for Doxycycline capsules IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited